Market News How it works Learn FAQ
| RCT 0.132 73.46% | NU 12.36 -18.47% | EWZ 33.885 -20.44% | TGL 0.254 14.67% | SRTM 0.326 -24.24% | BBD 2.855 -29.85% | ITUB 7.6 -21.41% | AZTR 1.615 125.87% | SHFS 0.103 -22.21% | XP 15.575 -48.78% | GCDT 0.1361 -22.71% | CLRO 4.79 47.38% | SOXL 91.64 9.67% | SPCX 149.92 1.65% | NWGL 0.0829 1.10% | PBR 21.94 -16.13% | NVD 3.99 -4.77% | SGRY 23.0703 46.48% | TSLL 10.9599 12.29% | VALE 11.99 -3.31% | RBNE 0.1701 -10.47% | CRWV 57.4626 5.95% | INTC 90.785 4.40% | NVDA 216.2072 2.49% | SOXS 47.41 -9.63% | BITO 10.77 -0.55% | ABEV 2.8 -15.15% | IREN 26.5486 6.60% | JBLU 2.295 -12.57% | NOK 8.625 5.96% | XTND 2.2 24.29% | SPRC 1.5001 37.62% | GPUS 0.1782 5.51% | TQQQ 69.14 4.30% | SBS 4.765 -25.55% | INTR 4.6286 -35.62% | TSLG 5.48 12.53% | RWM 14.435 -0.79% | TSLA 395.443 6.24% | SPDN 8.475 -0.76% | SQQQ 37.975 -4.30% | AAL 12.2055 0.79% | SID 0.9269 -21.45% | GGB 4.765 -6.57% | PBR-A 19.3388 -17.81% | RENT 2.9015 26.15% | LUCD 0.5155 25.43% | CIFR 8.1475 2.61% | KORU 10.9537 3.53% | WULF 12.08 6.71%
ZIZIVO Bioscience, Inc. logo

ZIVO Bioscience, Inc. (ZIVO)

Other OTC · Currency in USD
$6.25 ▲ +0.10 (+1.63%)
As of Oct 23, 4:00 PM ET. Market open.

Summary

Previous Close
$6.15
Open
$6.25
Day's Range
$6.25 – $6.25
52 Week Range
$1.11 – $17.50
Volume
101
Avg. Volume
995
Market Cap
$24.30M
Beta (5Y Monthly)
0.11
PE Ratio (TTM)
--
EPS (TTM)
-$1.33
Earnings Date
Dec 2, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$12.00

Profile: ZIVO Bioscience, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
7
CEO
John Bernard Payne

ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods. The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio.

Earnings

Next report: Wed, Dec 2, 2026
EPS estimate -$0.26 · Revenue est. $351.00K
DateEst.Actual
Aug 13, 2026-$0.28-$0.12Beat
May 15, 2026-$0.30-$0.24Beat
Feb 25, 2026-$0.29-$0.29Beat
Nov 14, 2025-$0.27-$0.27Beat
Aug 14, 2025-$0.41-$0.43Miss
May 15, 2025-$0.52-$1.12Miss

Analyst view

Consensus price target
$12.00 ▲ +92.0%
Range $12.00 – $12.00
Rating: Hold
Buy 0% · Hold 100% · Sell 0%

Get free alerts on ZIVO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.